Skip to content

Released Aug 7, 2024, after the close

10-Q filed Aug 8, 2024, 39 days after period end · 0001636422-24-000120

Q2 2024 · 10-Q
Revenue$75.90M+3.7% vs Q2 2023+1.6% vs Q1 2024
Net Income-$13.52MN/M vs Q2 2023N/M vs Q1 2024
EPS Diluted-$0.23N/M vs Q2 2023N/M vs Q1 2024
Operating Income-$15,807,000N/M
Operating Cash Flowderived$1,612,000N/M
Free Cash Flowderived$1,322,000N/M
Margins · derived
Operating margin-20.8%+26.5 pt vs Q2 2023
Net margin-17.8%+26.7 pt vs Q2 2023

What the release said

The release

Same quarter

MetricQ2 2024Q2 2023Q2 2022Q2 2021
Revenue$75.90M$73.21M$70.63M$59.63M
Net Income-$13.52M-$32.61M-$33.43M-$35.83M
EPS Diluted-$0.23-$0.58-$0.62-$0.80

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR